SonoThera Launches $125M Series B. Learn more here.
Category

Press Release

SonoThera logo
Press Release,

SonoThera Presents New Preclinical Data at MDA 2026 Highlighting RIPPLE™ as an Efficient, Scalable, Nonviral Platform for Full-Length Dystrophin Delivery in DMD

South San Francisco, CA, March 5, 2026 – SonoThera™, a biotechnology company dedicated to addressing the...
March 5, 2026
By Elizabeth Harness
SonoThera logo
Press Release,

SonoThera Launches $125M Series B at 44th J.P. Morgan Healthcare Conference to Advance Multiple Genetic Medicine Programs

South San Francisco, CA, January 8, 2026 – SonoThera™, a biotechnology company dedicated to treating the...
January 8, 2026
By dev_team
SonoThera logo
Press Release,

SonoThera Presents New Data at ASH 2025 Demonstrating Durable Factor VIII Expression Using Ultrasound Mediated Gene Delivery in Treating Hemophilia A

South San Francisco, CA, December 8, 2025 – SonoThera™, a biotechnology company dedicated to treating the...
December 8, 2025
By dev_team
SonoThera logo
Press Release,

SonoThera Presents New Data at ASN Kidney Week 2025 Demonstrating Full-Length Col4a5 Gene Expression Using Ultrasound Mediated Gene Delivery in Treating X-Linked Alport Syndrome

South San Francisco, CA, November 5, 2025 – SonoThera™, a biotechnology company dedicated to treating the...
November 5, 2025
By dev_team
SonoThera logo
Press Release,

SonoThera™ Presents New Data at ESGCT 2025 Demonstrating Expression of Full-Length Human Dystrophin Using Targeted, Ultrasound-Mediated Delivery to Treat Duchenne Muscular Dystrophy

South San Francisco, CA, October 7, 2025 – SonoThera™, a biotechnology company dedicated to treating the...
October 7, 2025
By dev_team
SonoThera logo
Press Release,

SonoThera™ to Present New Data at ASGCT 2025 Demonstrating the Potential of Genetic Medicine Using Targeted, Ultrasound-Mediated Delivery in Treating Duchenne Muscular Dystrophy and Hemophilia A

South San Francisco, CA, May 06, 2025 – SonoThera™, a biotechnology company dedicated to treating the...
May 6, 2025
By dev_team
SonoThera logo
Press Release,

SonoThera Presents New Data at the American Society of Hematology (ASH) Annual Meeting Demonstrating the Potential of Targeted, Ultrasound-Mediated Gene Delivery to Liver

South San Francisco, CA, December 02, 2024 – SonoThera™, a biotechnology company dedicated to treating...
December 2, 2024
By dev_team
SonoThera logo
Press Release,

SonoThera Presents New Data at the ASGCT Breakthroughs in Muscular Dystrophy Meeting on Ultrasound-Mediated Gene Delivery (UMGD) to Heart and Skeletal Muscle

South San Francisco, CA, November 14, 2024 – SonoThera™, a biotechnology company dedicated to treating...
November 14, 2024
By dev_team
SonoThera logo
Press Release,

SonoThera to Present Preclinical Data on Ultrasound-Mediated Gene Delivery Platform to the Heart at the American Heart Association (AHA) Scientific Sessions 2024

South San Francisco, CA, November 11, 2024 – SonoThera™, a biotechnology company dedicated to treating...
November 11, 2024
By dev_team

Inquiries about our Clinical Research

Contact Us